Ratings by Chardan (Matthew Barcus)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/14/2023 | Zura Bio | ZURA | New Coverage | Buy (N/A) |
8.16 (3.29) |
-59.68% | Details | |
| 12/23/2022 | Anixa Biosciences | ANIX | New Coverage | Buy (N/A) |
3.81 (2.93) |
-23.1% | Details | |
| 12/21/2022 | Xilio Therapeutics Inc | XLO | New Coverage | Buy (N/A) |
1.97 (7.31) |
271.07% | Details | |
| 9/8/2022 | Purple Biotech Ltd. | PPBT | New Coverage | Buy (N/A) |
2.27 (1.01) |
-55.51% | Details |
